The Food and Drug Administration (FDA) has approved a supplemental Biologics License Application (sBLA) for Keytruda (pembrolizumab) for the treatment of metastatic non-small cell lung cancer (NSCLC) in patients whose disease has progressed after other treatments and with tumors that express PD-L1.
A new study is raising safety concerns about the high rate of new opioid use among older adults with chronic obstructive pulmonary disease (COPD).
The benefits of psychological therapy for depression are overstated, according to research published in PLOS ONE.
Patients with obstructive sleep apnea (OSA) are at increased risk for depression, but continuous positive airway pressure (CPAP) therapy may ease their depression symptoms.
Tall stature may be linked with an increased risk for premature death in kidney failure patients on dialysis.
A study of more than five million Swedish men and women suggests that greater height may mean greater risk of cancer.
Patients with ankylosing spondylitis (AS) have lower serotonin levels than healthy controls and patients with rheumatoid arthritis (RA).
For patients undergoing total hip arthroplasty (THA) or total knee arthroplasty (TKA), increased body mass index (BMI) is protective against blood transfusions.
Habit reversal (HR) seems to be beneficial for reducing scratching among patients with atopic dermatitis (AD), according to a review published in the British Journal of Dermatology.
For patients with type 2 diabetes mellitus (T2DM) treated with metformin, add-on sitagliptin is associated with a lower risk of insulin initiation than add-on sulphonylurea.